We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Spruce Power Holding Corp
SPRU
$38.6M
| $216K | ﹤0.01% |
30,300
-23,213
| -43% | -$220K |
|
2177
Spyre Therapeutics
SYRE
$8.68B
| $216K | ﹤0.01% |
16,396
+7,128
| +77% | +$88.1K |
|
|
LYRA
2178
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $214K | ﹤0.01% |
856
+88
| +11% | +$26K |
|
|
ACR
2179
ACRES Commercial Realty
ACR
$129M
| $213K | ﹤0.01% |
26,167
-4,300
| -14% | -$38.7K |
|
2180
Civeo
CVEO
$376M
| $213K | ﹤0.01% |
+8,466
| New | +$230K |
|
2181
Douglas Emmett
DEI
$2.01B
| $213K | ﹤0.01% |
+11,900
| New | +$254K |
|
2182
National Bankshares
NKSH
$254M
| $213K | ﹤0.01% |
6,300
-1,100
| -15% | -$36.1K |
|
2183
Collegium Pharmaceutical
COLL
$1.16B
| $211K | ﹤0.01% |
+13,200
| New | +$233K |
|
2184
Meridian
MRBK
$241M
| $210K | ﹤0.01% |
14,400
-5,600
| -28% | -$83.2K |
|
2185
West Fraser Timber
WFG
$5.28B
| $210K | ﹤0.01% |
+2,900
| New | +$252K |
|
|
STSA
2186
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $209K | ﹤0.01% |
34,800
-2,800
| -7% | -$15.9K |
|
2187
Matthews International
MATW
$900M
| $208K | ﹤0.01% |
9,300
-3,800
| -29% | -$98.8K |
|
2188
Glaukos
GKOS
$8.89B
| $207K | ﹤0.01% |
+3,891
| New | +$201K |
|
2189
Laureate Education
LAUR
$5.28B
| $207K | ﹤0.01% |
19,600
-102,600
| -84% | -$1.16M |
|
2190
OP Bancorp
OPBK
$241M
| $207K | ﹤0.01% |
18,600
| – | – |
|
|
ZY
2191
DELISTED
Zymergen Inc. Common Stock
ZY
| $206K | ﹤0.01% |
74,100
-77,300
| -51% | -$188K |
|
2192
Vipshop
VIPS
$7.13B
| $205K | ﹤0.01% |
+24,400
| New | +$243K |
|
2193
Moelis & Co
MC
$5.1B
| $203K | ﹤0.01% |
6,000
-2,800
| -32% | -$117K |
|
2194
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
| $203K | ﹤0.01% |
+4,600
| New | +$225K |
|
2195
Cheesecake Factory
CAKE
$4.42B
| $202K | ﹤0.01% |
+6,900
| New | +$209K |
|
2196
National Grid
NGG
$81.3B
| $201K | ﹤0.01% |
+4,205
| New | +$253K |
|
|
LNAI
2197
Lunai Bioworks
LNAI
$10.2M
| $201K | ﹤0.01% |
1,390
+912
| +191% | +$166K |
|
|
BRMK
2198
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $201K | ﹤0.01% |
39,400
+7,600
| +24% | +$50.9K |
|
2199
PRA Group
PRAA
$688M
| $200K | ﹤0.01% |
+6,100
| New | +$227K |
|
|
VCSA
2200
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $200K | ﹤0.01% |
3,265
+670
| +26% | +$46.4K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.